دورية أكاديمية
أعرض في EDS

Malaria vaccination in Africa: A mini-review of challenges and opportunities.

التفاصيل البيبلوغرافية
العنوان: Malaria vaccination in Africa: A mini-review of challenges and opportunities.
المؤلفون: Olawade DB; Department of Allied and Public Health, School of Health, Sport and Bioscience, University of East London, London, UK., Wada OZ; Division of Sustainable Development, College of Science and Engineering, Hamad Bin Khalifa University, Qatar Foundation, Doha, Qatar., Ezeagu CN; Department of Public Health, School of Health and Life Sciences, Teesside University, Middlesbrough, UK., Aderinto N; Department of Medicine and Surgery, Ladoke Akintola University of Technology, Ogbomoso, Nigeria., Balogun MA; Department of Public Health, University of Suffolk, UK., Asaolu FT; Department of Biomedical Science, De Montfort University, UK., David-Olawade AC; Department of Nursing, University of Derby, Derby, UK.
المصدر: Medicine [Medicine (Baltimore)] 2024 Jun 14; Vol. 103 (24), pp. e38565.
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 2985248R Publication Model: Print Cited Medium: Internet ISSN: 1536-5964 (Electronic) Linking ISSN: 00257974 NLM ISO Abbreviation: Medicine (Baltimore) Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Hagerstown, Md : Lippincott Williams & Wilkins
مواضيع طبية MeSH: Malaria Vaccines*/administration & dosage , Malaria Vaccines*/therapeutic use , Malaria*/prevention & control, Humans ; Africa/epidemiology ; Vaccination ; Africa South of the Sahara/epidemiology
مستخلص: Malaria remains an endemic public health concern in Africa, significantly contributing to morbidity and mortality rates. The inadequacies of traditional prevention measures, like integrated vector management and antimalarial drugs, have spurred efforts to strengthen the development and deployment of malaria vaccines. In addition to existing interventions like insecticide-treated bed nets and artemisinin-based combination therapies, malaria vaccine introduction and implementation in Africa could drastically reduce the disease burden and hasten steps toward malaria elimination. The malaria vaccine rollout is imminent as optimistic results from final clinical trials are anticipated. Thus, determining potential hurdles to malaria vaccine delivery and uptake in malaria-endemic regions of sub-Saharan Africa will enhance decisions and policymakers' preparedness to facilitate efficient and equitable vaccine delivery. A multisectoral approach is recommended to increase funding and resources, active community engagement and participation, and the involvement of healthcare providers.
Competing Interests: The authors have no funding and conflicts of interest to disclose.
(Copyright © 2024 the Author(s). Published by Wolters Kluwer Health, Inc.)
References: EClinicalMedicine. 2022 Jun;48:101454. (PMID: 35611343)
Curr Epidemiol Rep. 2021;8(2):46-62. (PMID: 33747712)
Malar J. 2022 Nov 16;21(1):339. (PMID: 36384655)
Nat Med. 2021 Sep;27(9):1506-1509. (PMID: 34518678)
Hum Vaccin Immunother. 2020 Mar 3;16(3):480-489. (PMID: 31545128)
BMJ Glob Health. 2022 Apr;7(Suppl 1):. (PMID: 35414522)
Malar J. 2020 Mar 4;19(1):105. (PMID: 32131834)
Vaccine. 2017 Apr 19;35(17):2217-2223. (PMID: 27670076)
Pan Afr Med J. 2021 Jan 05;38:3. (PMID: 33520072)
Int J Health Policy Manag. 2020 Jul 01;9(7):274-285. (PMID: 32613799)
N Engl J Med. 2021 Sep 9;385(11):1005-1017. (PMID: 34432975)
Vaccine. 2019 Aug 14;37(35):4928-4936. (PMID: 31326253)
Lancet. 2015 Jul 4;386(9988):31-45. (PMID: 25913272)
Nature. 2019 Nov;575(7781):119-129. (PMID: 31695203)
Arch Public Health. 2021 Jan 4;79(1):1. (PMID: 33390163)
Lancet Infect Dis. 2022 Dec;22(12):1728-1736. (PMID: 36087586)
PLoS One. 2020 Aug 4;15(8):e0235697. (PMID: 32750051)
Cell. 2022 Mar 3;185(5):750-754. (PMID: 35245476)
Vaccine. 2020 Jul 14;38(33):5364-5371. (PMID: 32563607)
Nat Commun. 2019 Apr 9;10(1):1633. (PMID: 30967543)
Trop Med Infect Dis. 2022 Aug 30;7(9):. (PMID: 36136626)
Trials. 2019 May 31;20(1):316. (PMID: 31151473)
Glob Public Health. 2022 May;17(5):768-781. (PMID: 33487104)
Ann Med Surg (Lond). 2022 Jul;79:104031. (PMID: 35761818)
Malar J. 2021 Sep 8;20(1):364. (PMID: 34493280)
Am J Trop Med Hyg. 2017 Sep;97(3_Suppl):6-8. (PMID: 28990917)
Parasit Vectors. 2018 Aug 13;11(1):464. (PMID: 30103825)
F1000Res. 2020 Apr 27;9:. (PMID: 32399189)
Malar J. 2023 Aug 23;22(1):242. (PMID: 37612716)
Front Public Health. 2019 Mar 20;7:56. (PMID: 30949465)
J Clin Invest. 2010 Dec;120(12):4168-78. (PMID: 21123952)
Lancet Infect Dis. 2022 Sep;22(9):1329-1342. (PMID: 35753316)
J Infect Dis. 2019 Sep 26;220(9):1444-1452. (PMID: 31249999)
Confl Health. 2019 Oct 29;13:49. (PMID: 31673285)
PLoS One. 2022 Dec 1;17(12):e0278224. (PMID: 36455209)
Hum Vaccin Immunother. 2022 Dec 31;18(1):1-3. (PMID: 33684019)
Int J Nanomedicine. 2019 Feb 21;14:1401-1410. (PMID: 30863068)
PLoS One. 2022 Jun 8;17(6):e0268009. (PMID: 35675273)
Expert Rev Vaccines. 2019 Feb;18(2):119-131. (PMID: 30689472)
Trop Med Infect Dis. 2023 Jan 16;8(1):. (PMID: 36668974)
Vaccine. 2019 Oct 8;37(43):6317-6323. (PMID: 31521412)
Malar J. 2022 May 12;21(1):147. (PMID: 35550113)
J Glob Health. 2022 Dec 23;12:03087. (PMID: 36560893)
Sci Transl Med. 2022 Jun 29;14(651):eabn3256. (PMID: 35767649)
Health Policy Plan. 2023 Jan 6;38(1):28-37. (PMID: 36083007)
Lancet. 2020 May 30;395(10238):1735-1738. (PMID: 32386564)
Cell. 2019 Sep 19;179(1):13-17. (PMID: 31519310)
Malar J. 2020 Aug 5;19(1):282. (PMID: 32758233)
EMBO Mol Med. 2022 Aug 8;14(8):e16287. (PMID: 35758210)
Ther Adv Vaccines Immunother. 2021 Sep 28;9:25151355211047514. (PMID: 34604696)
Immun Inflamm Dis. 2023 Jun;11(6):e899. (PMID: 37382251)
المشرفين على المادة: 0 (Malaria Vaccines)
تواريخ الأحداث: Date Created: 20240614 Date Completed: 20240614 Latest Revision: 20240618
رمز التحديث: 20240619
مُعرف محوري في PubMed: PMC11175883
DOI: 10.1097/MD.0000000000038565
PMID: 38875411
قاعدة البيانات: MEDLINE
الوصف
تدمد:1536-5964
DOI:10.1097/MD.0000000000038565